These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9293051)

  • 1. Comparison of clarithromycin suspension and amoxycillin syrup for the treatment of children with pharyngitis and/or tonsillitis.
    Kearsley NL; Campbell A; Sanderson AA; Weir RD; Kamdar MK; Coles SJ
    Br J Clin Pract; 1997; 51(3):133-7. PubMed ID: 9293051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
    Takker U; Dzyublyk O; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5-day therapy of bacterial pharyngitis and tonsillitis with cefixime. Comparison with 10 day treatment with penicillin V. Cefixime Study Group].
    Adam D; Hostalek U; Tröster K
    Klin Padiatr; 1996; 208(5):310-3. PubMed ID: 8992100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: comparison of 5 days of ER clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis.
    Hersh EV
    Curr Med Res Opin; 2004 Apr; 20(4):451-2. PubMed ID: 15119981
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J; Ruoff GE; Ziter PS
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
    O'Doherty B
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
    Brook I
    Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis.
    Yildirim I; Ceyhan M; Gür D; Kaymakoğlu I
    Turk J Pediatr; 2008; 50(2):120-5. PubMed ID: 18664074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial.
    Clegg HW; Ryan AG; Dallas SD; Kaplan EL; Johnson DR; Norton HJ; Roddey OF; Martin ES; Swetenburg RL; Koonce EW; Felkner MM; Giftos PM
    Pediatr Infect Dis J; 2006 Sep; 25(9):761-7. PubMed ID: 16940830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis.
    Derriennic M; Voi M; Thoren LM; Black SA; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S43-6; discussion S46-8. PubMed ID: 1287618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin).
    Kaplan EL; Gooch III WM; Notario GF; Craft JC
    Clin Infect Dis; 2001 Jun; 32(12):1798-802. PubMed ID: 11360224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies.
    Still JG; Hubbard WC; Poole JM; Sheaffer CI; Chartrand S; Jacobs R
    Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S134-41. PubMed ID: 8295815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis.
    McCarty J; Hedrick JA; Gooch WM
    Adv Ther; 2000; 17(1):14-26. PubMed ID: 10915400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptococcal pharyngo-tonsillitis: diagnostic and therapeutic approach].
    Baeza-Bacab MA
    Bol Med Hosp Infant Mex; 1987 Feb; 44(2):126-30. PubMed ID: 3548744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Streptococcal pharyngitis].
    Romero J; Betriu C
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):611-27. PubMed ID: 8808478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.